학술논문
Safety and clinical efficacy of the double switch from originator infliximab to biosimilars CT-P13 and SB2 in patients with inflammatory bowel diseases (SCESICS): A multicenter cohort study
Document Type
Article
Author
Mazza, S.; Piazza O. Sed, N.; Conforti, F.S.; Fascì, A.; Cavallaro, F.; Eugenio Tontini, G.; Vecchi, M.; Caprioli, F.; Rimondi, A.; Marinoni, B.; Casini, V.; Munari, F.; Ricci, C.; Pirola, L.; Invernizzi, P.; Girelli, C.; Lupinacci, G.; Pastorelli, L.; Ferraris, L.; Colucci, A.; Amato, A.; Fiorino, G.
Source
In: Clinical and Translational Science . (Clinical and Translational Science, January 2022, 15(1):172-181)
Subject
Language
English
ISSN
17528062
17528054
17528054